Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Richard Steinbrugger"'
Autor:
Thomas Höchtl, Walter Jäger, Monika Fritzer-Szekeres, Howard L. Elford, Georg Krupitza, Michael Grusch, Richard Steinbrugger, Alexandra Salamon, Zsuzsanna Horvath, Thomas Szekeres
Publikováno v:
Biochemical Pharmacology. 64:481-485
Ribonucleotide reductase is the rate-limiting enzyme for the de novo synthesis of deoxynucleoside triphosphates and therefore represents a good target for cancer chemotherapy. Trimidox (3,4,5-trihydroxybenzamidoxime) was identified as a potent inhibi
Autor:
Richard Steinbrugger, Alexandra Salomon, Walter Jäger, Monika Fritzer-Szekeres, Ahmad Hamwi, Thomas Szekeres
Publikováno v:
American Journal of Clinical Pathology. 114:536-543
Cyclosporine is used in the prevention of allograft rejection. Owing to its narrow therapeutic index, regular monitoring of the whole blood levels of cyclosporine is required. We observed that immunoassays measured significantly higher cyclosporine l
Autor:
Gerhard Fuhrmann, Katja Braun, Wolfgang Hulla, Andreas Chott, Markus Hengstschläger, Richard Steinbrugger, Michael Grusch, Ingrid Simonitsch, George Krupitza
Publikováno v:
Cell Death & Differentiation. 5:758-764
Tumor necrosis factor (TNFs) have been shown to be synthesized by ovarian carcinomas, and may therefore affect tumor cells in an autocrine manner. Therefore, we investigated the effects of recombinant TNFs on ovarian carcinoma cells N.1 and examined